Study of Lumateperone in the Treatment of Patients With Bipolar Mania

NCT06462612 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder, Manic

Interventions

DRUG: Lumateperone
DRUG: Placebo

Sponsor

Intra-Cellular Therapies, Inc.